MOEXA
LIVE

Serial Number

99572306

Owner

Moexa Pharmaceuticals Limited

Attorney

Joseph G. Chu

Filing Date

Dec 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MOEXA Trademark

Serial Number: 99572306

MOEXA is a trademark filed by Moexa Pharmaceuticals Limited on December 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Moexa Pharmaceuticals Limited

Unit 1601, 16th Floor, Metropole Square
Shek Mun , HK

Entity Type: 99

Trademark Details

Filing Date

December 30, 2025

Registration Date

Not Registered

Published for Opposition

September 1, 2026

Goods & Services

Pharmaceutical preparations for the treatment and prevention of cancer and fibrosis; Pharmaceutical preparations for medical purposes, namely, for treatment and prevention of lung cancer, colorectal cancer, lymph node cancer, bone cancer, gastric cancer, melanoma, pancreatic cancer, breast cancer, liver cancer, prostate cancer, pulmonary fibrosis, idiopathic pulmonary fibrosis, post-viral fibrosis, post coronavirus fibrosis, cystic fibrosis or fibrosis resulting from radiation, renal fibrosis, cardiac fibrosis, liver fibrosis, arthrofibrosis, nephrogenic systemic fibrosis, retroperitoneal fibrosis, scleroderma/systemic sclerosis, myelofibrosis or mediastinal fibrosis, fibrosis associated with arterial stiffness, Crohn's disease, Dupuytren's contracture, keloids, Peyronie's disease or adhesive capsulitis, and inflammation of the body of a human subject; Medical preparations for the treatment of cancer and fibrosis; Veterinary pharmaceutical preparations for the treatment of cancer and fibrosis; Medicaments for the treatment and prevention of cancer and fibrosis; Anti-cancer preparations; Medicaments for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment, inhibition or prevention of cell proliferation; chemical preparations and medicaments for pharmaceutical or medical purposes, namely, for treatment, inhibition or prevention of cancer and fibrosis; Veterinary pharmaceutical preparations for the prevention of cancer and fibrosis; Pharmaceutical preparations for the prevention of cell proliferation; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the prevention of fibrosis; Medicaments for the prevention of fibrosis; Dietetic foods adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic pet foods adapted for veterinary use; Dietetic pet foods adapted for veterinary purposes; Dietary supplements for humans and animals; Pharmaceutical preparations for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for the prevention of cell proliferation; Medicaments for the prevention of cancer

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 1, 2026 NPUB
PUBLISHED FOR OPPOSITION
Sep 1, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 7, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 7, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 29, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 30, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2025 NWOS
NEW APPLICATION ENTERED
Dec 30, 2025 NWAP